Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene

被引:32
|
作者
Schufreider, Ann [1 ]
McQueen, Dana B. [1 ]
Lee, Sang Mee [2 ]
Allon, Rachel [3 ]
Uhler, Meike L. [4 ]
Davie, Jocelyn [5 ]
Feinberg, Eve C. [1 ,4 ,6 ]
机构
[1] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Fertil Ctr Illinois, Chicago, IL 60610 USA
[5] Good Start Genet Inc, Cambridge, MA 02139 USA
[6] NorthShore Univ Hlth Syst, Dept Obstet & Gynecol, Evanston, IL 60201 USA
关键词
infertility; FMR1; gene; anti-Mullerian hormone; ovarian reserve; genetic counseling; WOMEN; INTERMEDIATE; PREMUTATION; ASSOCIATION; PREVALENCE; MUTATIONS; SIZES; RANGE;
D O I
10.1093/humrep/dev220
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION: Does an association exist between high normal numbers of CGG trinucleotide repeats on the fragile X mental retardation 1 (FMR1) gene and diminished ovarian reserve (DOR)? SUMMARY ANSWER: This large data set demonstrated that a high normal number of CGG repeats (35-54 repeats) on the FMR1 gene was not significantly correlated with DOR. WHAT IS KNOWN ALREADY: The FMR1 premutation (55-200 repeats) is a known cause of primary ovarian insufficiency. However, the relationship between high normal CGG repeat numbers (35-54 repeats) and ovarian reserve has yet to be conclusively demonstrated. STUDY DESIGN, SIZE, DURATION: This is a retrospective data analysis conducted between January 2012 and February 2014 that included 1287 women. Over 1140 women had complete data. PARTICIPANTS/MATERIALS, SETTING, METHODS: All women, excluding oocyte donors, who presented to a large private practice specializing in reproductive endocrinology and infertility for treatment and who underwent both fragile X and ovarian reserve testing were included. All fragile X testing was performed using triplet repeat PCR, with confirmation of positives by Southern blot. CGG repeat numbers from both alleles were recorded, and the allele with the higher number of repeats was used for statistical calculations. We did not differentiate between patients with one or two high normal alleles. Women with >54 CGG repeats were excluded from the analysis. For our analysis, we considered both a 'high normal' number of CGG repeats (35-44) and an intermediate number of GCC repeats (45-54) as 'high normal'. Ovarian reserve testing was carried out on Cycle Day 2 or 3 and included measurements of FSH, anti-Mullerian hormone (AMH) and antral follicle count (AFC). A generalized linear regression model assuming gamma distribution and log link function that controlled for age was used to assess correlation between CGG repeat number and FSH, AMH and AFC. MAIN RESULTS AND THE ROLE OF CHANCE: As expected, there was a significant correlation between increasing age and increasing FSH and decreasing AFC and AMH for the patients in this study. For every 1-year increase in age, FSH increased by a factor of 1.04, AFC decreased by a factor of 0.93 and AMH decreased by a factor of 0.89. After controlling for age, there was no significant correlation between FMR1 CGG trinucleotide repeat number and FSH (P = 0.23), AFC (P = 0.14) or AMH (P = 0.53). Three subgroup analyses were also performed. We found a significant relationship between increasing CGG repeat number and decreasing AMH levels (P = 0.01) in women >44 years old. The second subgroup analysis included only Caucasian patients and found no significant correlation between CGG repeat number and DOR. In a subgroup analysis comparing women with at least one allele <26 repeats, at least one allele >35 and women with both alleles between 29 and 32, there were no significant associations regarding ovarian reserve in any of these groups. LIMITATIONS, REASONS FOR CAUTION: One limitation of this study is that it involved a heterogeneous population of infertile women with mixed diagnoses. Factors that could affect ovarian reserve, such as medical comorbidities, prior surgeries, family history and endometriosis, were not accounted for. Finally, there was a lack of racial diversity, with Caucasians representing 67.8% of the total population. WIDER IMPLICATIONS OF THE FINDINGS: The findings of this study are generalizable to an infertility population and are in line with several previously published studies. Women who are found to have high normal CGG repeat numbers can be counseled that this is not causative for DOR. Further studies are needed to investigate whether increasing CGG repeat numbers are associated with ovarian responsiveness to gonadotrophin stimulation or IVF outcome.
引用
收藏
页码:2686 / 2692
页数:7
相关论文
共 50 条
  • [1] HIGH NORMAL CGG REPEAT NUMBER ON THE FRAGILE X MENTAL RETARDATION 1 (FMR1) GENE IS NOT CORRELATED WITH DIMINISHED OVARIAN RESERVE.
    Schufreider, A.
    Uhler, M. L.
    Lee, S. M.
    Marut, E. L.
    McQueen, D. B.
    Davie, J.
    Feinberg, E. C.
    FERTILITY AND STERILITY, 2014, 102 (03) : E76 - E76
  • [2] Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve
    Gleicher, Norbert
    Weghofer, Andrea
    Oktay, Kutluk
    Barad, David
    REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (03) : 385 - 390
  • [3] Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test?
    Gleicher, Norbert
    Weghofer, Andrea
    Oktay, Kutluk
    Barad, David H.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (09) : 1024 - 1030
  • [4] The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve
    Ruiyi Tang
    Qi Yu
    Reproductive Biology and Endocrinology, 18
  • [5] The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve
    Tang, Ruiyi
    Yu, Qi
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)
  • [6] FRAGILE X MENTAL RETARDATION 1 (FMR1) GENE CGG REPEAT NUMBER AND PREGNANCY LOSS.
    McQueen, D.
    Allon, R.
    Schufreider, A.
    Uhler, M. L.
    Feinberg, E.
    FERTILITY AND STERILITY, 2015, 104 (03) : E348 - E348
  • [7] VARIATION WITHIN THE NORMAL RANGE IN FRAGILE X MENTAL RETARDATION 1 (FMR1) GENE CGG REPEAT NUMBER IS NOT PREDICTIVE OF OVARIAN RESPONSIVENESS DURING IVF
    Werner, M. D.
    Hong, K.
    Duffy, L.
    Forman, E.
    Devkota, B.
    Scott, R.
    FERTILITY AND STERILITY, 2012, 98 (03) : S104 - S104
  • [8] Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene
    Zumwalt, Marta
    Ludwig, Anna
    Hagerman, Paul J.
    Dieckmann, Thorsten
    RNA BIOLOGY, 2007, 4 (02) : 93 - 100
  • [9] Assessment of FMR1 triplet repeats in patients affected with mental retardation, fragile X syndrome and primary ovarian insufficiency
    Salimy, Zeinab
    Akbari, Mohammad Taghi
    Khordadpoor Deilamani, Faravareh
    JOURNAL OF GENETICS, 2020, 99 (01)
  • [10] Assessment of FMR1 triplet repeats in patients affected with mental retardation, fragile X syndrome and primary ovarian insufficiency
    Zeinab Salimy
    Mohammad Taghi Akbari
    Faravareh Khordadpoor Deilamani
    Journal of Genetics, 2020, 99